logo 600X600.png
Clinical Trial Software Market Surges to US$ 2.3 Billion by 2031, Propelled by 14.3% CAGR, States CoherentMI
September 10, 2024 11:01 ET | CMI
Burlingame, Sept. 10, 2024 (GLOBE NEWSWIRE) -- CoherentMI published a report, titled, Clinical Trial Software Market is estimated to value at US$ 0.9 Billion in the year 2024, and is anticipated to...
eClinical Solutions Market
eClinical Solutions Market to Cross $22.1 Billion by 2029: Analysis of Market Trends, the Ecosystem, Case Studies, Regulatory Landscape, Patents, Technologies, Pricing, and the Competitive Landscape
September 02, 2024 09:25 ET | Research and Markets
Dublin, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The "eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, Safety), Deployment (On premise, Cloud), Application (Collection,...
Clinical ink announc
Clinical ink announces EDCXtra™: An integrated web-based EDC, DDC and eCOA platform
August 29, 2024 11:36 ET | Clinical Ink
Winston Salem, NC, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, announced the launch of EDCXtraTM, an innovative Electronic Data Capture (EDC) system. ...
Y-Prime, LLC
YPrime Launches Breakthrough eCOA Platform to Deliver Up to 30% Faster Implementations
July 24, 2024 09:00 ET | Y-Prime, LLC
YPrime releases groundbreaking eCOA platform to revolutionize the clinical trial landscape.
Global ePRO, E-Patient Diaries and eCOA Market
ePRO, E-Patient Diaries and eCOA Global Strategic Report 2024, Featuring Anju Software, ArisGlobal and Castor EDC
July 11, 2024 11:08 ET | Research and Markets
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "ePRO, E-Patient Diaries and eCOA - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for ePRO,...
Y-Prime, LLC 2024
YPrime Research Reveals User-Centric eCOA Technologies as Key to Overcoming Challenges in Endocrinology Clinical Trials
June 25, 2024 08:00 ET | Y-Prime, LLC
New YPrime research report sheds light on how technology can help solve challenges in endocrinology clinical trials.
Kyle Hogan, Chief Executive Officer, Datacubed Health
Datacubed Health Sharpens Focus on eCOA and ePRO With New CEO
May 21, 2024 08:00 ET | Datacubed Health
King of Prussia, PA., May 21, 2024 (GLOBE NEWSWIRE) -- Datacubed Health, a leading provider of innovative technology solutions for clinical trials, today announced the appointment of Kyle Hogan as...
Y-Prime, LLC
YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality
May 21, 2024 08:00 ET | Y-Prime, LLC
YPrime's new glucometer/eCOA functionality offers a patient-centric, intuitive, and connected experience to clinical trial participants.
Lindsay Daniel
YPrime Appoints Lindsay Daniel as Chief Human Resources Officer
May 14, 2024 08:00 ET | Y-Prime, LLC
YPrime’s newly appointed Chief Human Resources Officer, Lindsay Daniel, will lead YPrime's global HR strategy.
YPrime CNS Survey - Key eCOA Attributes
New YPrime Report Highlights eCOA's Impact on CNS Trials
May 01, 2024 08:00 ET | Y-Prime, LLC
YPrime has released a new report, Insights into CNS Clinical Trials, which demonstrates to sponsors how eCOA can help streamline CNS research.